Entering text into the input field will update the search result below

Apheresis Market Worth $2.7 Billion By 2025

May 14, 2021 11:01 AM ET
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.


  • Rising Prevalence of Chronic Diseases and Growing Number of Trauma and Injury Cases.
  • Increasing Demand for Source Plasma From Biopharmaceutical Companies.
  • Rising Demand for Blood Components and Growing Concerns Regarding Blood Safety.
  • Increase in the Number of Complex Surgical Procedures.
  • Favorable Reimbursement for Apheresis Procedures.

Overview of the Apheresis Market:

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research:

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the apheresis market.

It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research:

In the primary research process, industry experts from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Industry experts from the supply side include CEOs, vice presidents, marketing and sales directors, product managers, business development managers, technology and innovation directors of companies providing apheresis, key opinion leaders, and suppliers and distributors. The industry experts from the demand side include hospitals, blood collection centers, transfusion clinics, and healthcare payers.

Download PDF Brochure@ Apheresis Market

What the Market Looks Like?

The global apheresis market is expected to reach USD 2.7 billion by 2025 from an estimated value of USD 1.7 billion in 2019, growing at a CAGR of 8.1% during the forecast period.

Objectives of the Study:

# To define, describe, and forecast the global apheresis market by product, technology, application, procedure, end user, and region.

# To provide detailed information about the factors influencing the market growth (drivers, restraints, opportunities, and challenges).

# To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market.

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.

# To forecast the size of the apheresis market in five regions (along with major countries)—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.

# To profile key players in the apheresis market and comprehensively analyze their core competencies and market shares.

# To track and analyze competitive developments such as acquisitions; new product launches; collaborations, partnerships, and agreements; and R&D activities of the leading players in the global apheresis market

Request Sample Pages@ Apheresis Market

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.